162 related articles for article (PubMed ID: 38630135)
1. Intratumor injection of BCG Ag85A high-affinity peptides enhanced anti-tumor efficacy in PPD-positive melanoma.
Qin L; Zhang G; Wu Y; Yang Y; Zou Z
Cancer Immunol Immunother; 2024 Apr; 73(6):103. PubMed ID: 38630135
[TBL] [Abstract][Full Text] [Related]
2. Intranasal boosting with MVA encoding secreted mycobacterial proteins Ag85A and ESAT-6 generates strong pulmonary immune responses and protection against M. tuberculosis in mice given BCG as neonates.
Khanna M; Rady H; Dai G; Ramsay AJ
Vaccine; 2021 Mar; 39(12):1780-1787. PubMed ID: 33632562
[TBL] [Abstract][Full Text] [Related]
3. BCG hydrogel promotes CTSS-mediated antigen processing and presentation, thereby suppressing metastasis and prolonging survival in melanoma.
Kremenovic M; Chan AA; Feng B; Bäriswyl L; Robatel S; Gruber T; Tang L; Lee DJ; Schenk M
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35732347
[TBL] [Abstract][Full Text] [Related]
4. Protective efficacy of recombinant (Ag85A) BCG Tokyo with Ag85A peptide boosting against Mycobacterium tuberculosis-infected guinea pigs in comparison with that of DNA vaccine encoding Ag85A.
Sugawara I; Udagawa T; Taniyama T
Tuberculosis (Edinb); 2007 Mar; 87(2):94-101. PubMed ID: 16815096
[TBL] [Abstract][Full Text] [Related]
5. Recombinant BCG Expressing Mycobacterium ulcerans Ag85A Imparts Enhanced Protection against Experimental Buruli ulcer.
Hart BE; Hale LP; Lee S
PLoS Negl Trop Dis; 2015 Sep; 9(9):e0004046. PubMed ID: 26393347
[TBL] [Abstract][Full Text] [Related]
6. Investigation of immunogenic effect of the BCG priming and Ag85A- GM-CSF boosting in Balb/c mice model.
Dou J; Tang Q; Yu F; Yang H; Zhao F; Xu W; Wang J; Hu W; Hu K; Liou C; Feng He X; Wang Y
Immunobiology; 2010; 215(2):133-42. PubMed ID: 19450898
[TBL] [Abstract][Full Text] [Related]
7. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
[TBL] [Abstract][Full Text] [Related]
8. Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin.
Ylösmäki E; Fusciello M; Martins B; Feola S; Hamdan F; Chiaro J; Ylösmäki L; Vaughan MJ; Viitala T; Kulkarni PS; Cerullo V
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34266884
[TBL] [Abstract][Full Text] [Related]
9. Intranasal immunization with peptide-based immunogenic complex enhances BCG vaccine efficacy in a murine model of tuberculosis.
Kumar S; Bhaskar A; Patnaik G; Sharma C; Singh DK; Kaushik SR; Chaturvedi S; Das G; Dwivedi VP
JCI Insight; 2021 Feb; 6(4):. PubMed ID: 33444288
[TBL] [Abstract][Full Text] [Related]
10. Distinct effector memory CD4+ T cell signatures in latent Mycobacterium tuberculosis infection, BCG vaccination and clinically resolved tuberculosis.
Adekambi T; Ibegbu CC; Kalokhe AS; Yu T; Ray SM; Rengarajan J
PLoS One; 2012; 7(4):e36046. PubMed ID: 22545156
[TBL] [Abstract][Full Text] [Related]
11. rBCG induces strong antigen-specific T cell responses in rhesus macaques in a prime-boost setting with an adenovirus 35 tuberculosis vaccine vector.
Magalhaes I; Sizemore DR; Ahmed RK; Mueller S; Wehlin L; Scanga C; Weichold F; Schirru G; Pau MG; Goudsmit J; Kühlmann-Berenzon S; Spångberg M; Andersson J; Gaines H; Thorstensson R; Skeiky YA; Sadoff J; Maeurer M
PLoS One; 2008; 3(11):e3790. PubMed ID: 19023426
[TBL] [Abstract][Full Text] [Related]
12. Increased B and T Cell Responses in M. bovis Bacille Calmette-Guérin Vaccinated Pigs Co-Immunized with Plasmid DNA Encoding a Prototype Tuberculosis Antigen.
Bruffaerts N; Pedersen LE; Vandermeulen G; Préat V; Stockhofe-Zurwieden N; Huygen K; Romano M
PLoS One; 2015; 10(7):e0132288. PubMed ID: 26172261
[TBL] [Abstract][Full Text] [Related]
13. Using a prime and pull approach, lentivector vaccines expressing Ag85A induce immunogenicity but fail to induce protection against Mycobacterium bovis bacillus Calmette-Guérin challenge in mice.
Britton G; MacDonald DC; Brown JS; Collins MK; Goodman AL
Immunology; 2015 Oct; 146(2):264-70. PubMed ID: 26095282
[TBL] [Abstract][Full Text] [Related]
14. Protection associated with a TB vaccine is linked to increased frequency of Ag85A-specific CD4(+) T cells but no increase in avidity for Ag85A.
Metcalfe HJ; Steinbach S; Jones GJ; Connelley T; Morrison WI; Vordermeier M; Villarreal-Ramos B
Vaccine; 2016 Aug; 34(38):4520-4525. PubMed ID: 27498622
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.
Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA
Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942
[TBL] [Abstract][Full Text] [Related]
16. A lipidated peptide of Mycobacterium tuberculosis resuscitates the protective efficacy of BCG vaccine by evoking memory T cell immunity.
Rai PK; Chodisetti SB; Zeng W; Nadeem S; Maurya SK; Pahari S; Janmeja AK; Jackson DC; Agrewala JN
J Transl Med; 2017 Oct; 15(1):201. PubMed ID: 28985739
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of tuberculin and BCG immunoreactivity in stage I high-risk malignant melanoma (EORTC protocol 18781).
Henz BM; Macher E; Bröcker EB; Suciu S; Steerenberg PA; Jung E; Rümke P
Dermatology; 1996; 193(2):105-9. PubMed ID: 8884144
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of T-Cell Responses Against Shared Melanoma Associated Antigens and Predicted Neoantigens in Cutaneous Melanoma Patients Treated With the CSF-470 Allogeneic Cell Vaccine Plus BCG and GM-CSF.
Podaza E; Carri I; Aris M; von Euw E; Bravo AI; Blanco P; Ortiz Wilczyñski JM; Koile D; Yankilevich P; Nielsen M; Mordoh J; Barrio MM
Front Immunol; 2020; 11():1147. PubMed ID: 32582212
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of a Mycobacterium ulcerans Ag85B-EsxH Fusion Protein in Recombinant BCG Improves Experimental Buruli Ulcer Vaccine Efficacy.
Hart BE; Lee S
PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005229. PubMed ID: 27941982
[TBL] [Abstract][Full Text] [Related]
20. Using an effective TB vaccination regimen to identify immune responses associated with protection in the murine model.
Pinpathomrat N; Bull N; Pasricha J; Harrington-Kandt R; McShane H; Stylianou E
Vaccine; 2021 Mar; 39(9):1452-1462. PubMed ID: 33549390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
